The aggregation process of a series
of mono- and dinuclear gold(I)
complexes containing a 4-ethynylaniline ligand and a phosphane at
the second coordination position (PR3-Au-CCC6H4-NH2, complexes 1–5, and (diphos)(Au-CCC6H4-NH2)2, complexes 6–8), whose biological activity was previously studied by us, has been
carefully analyzed through absorption, emission, and NMR spectroscopy,
together with dynamic light scattering and small-angle X-ray scattering.
These experiments allow us to retrieve information about how the compounds
enter the cells. It was observed that all compounds present aggregation
in fresh solutions, before biological treatment, and thus they must
be entering the cells as aggregates. Inductively coupled plasma atomic
emission spectrometry measurements showed that mononuclear complexes
are mainly found in the cytosolic fraction; the dinuclear complexes
are mainly found in a subsequent fraction composed of nuclei and cytoskeleton.
Additionally, dinuclear complex 8 affects the actin aggregation
to a larger extent, suggesting a cooperative effect of dinuclear compounds.